Overview

Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Albuterol
Pharmaceutical Solutions